這劇本已經想好了，
前面接受國藥跟科興疫苗的中國人，
接著再打了BNT後，
中國政府會宣稱，BNT的效果是建立在國藥與科興疫苗的基礎之上。
皆下來就會大量把這成果送到國外去，
然後跟對方說，我的疫苗很有效，但是加上BNT的會更好唷，
BNT請自己去想辦法拿～揪瞇。
不過話說，中國不是也有在研究mRNA疫苗？
這時候放行BNT這中間是有什麼貓膩？
※ 引述《gibbs1286 (學無止境是國關)》之銘言：
: https://reurl.cc/4a88LV
: 路透社報導
: Fosun-BioNTech COVID-19 vaccine completes China regulator review - media
: SHANGHAI, July 15 (Reuters) - Chinese regulators have completed an expert
: review of a COVID-19 mRNA vaccine developed by Germany's BioNTech (22UAy.DE)
: and Fosun Pharma (600196.SS) and the shot is in the administration review
: stage, Caixin reported, citing the Chinese company.
: China hasn't approved any COVID-19 vaccine developed overseas but
: greenlighted several domestic brands, administering 1.4 billion doses so far,
: or two-fifths of the global total of 3.47 billion doses.
: BioNTech Chief Executive Ugur Sahin said in April he expected its COVID-19
: vaccine would win approval from the Chinese authorities "by June at the
: latest."
: BioNTech and Fosun did not immediately reply to Reuters' requests for comment.
: The vaccine is on track to begin trial production in China at the end of
: August, Caixin cited Fosun Pharma chairman Wu Yifang as saying at a
: shareholders' meeting on Wednesday.
: It said the vaccine would be used as a booster shot for people who have
: received vaccines using inactivated viruses.
: These are vaccines that use a coronavirus that cannot replicate in human
: cells and include Sinovac's (SVA.O) COVID-19 shot.
: 簡單來說就是中國政府對BNT疫苗已經通過專家審查，進入行政審查並預計作為那些打過
: 科興、國藥的人的第三針加強劑，然後八月底復星在中國開始試生產BNT疫苗
: 復星：反正你最後都還是要打BNT的，為什麼不一開始就打BNT呢，ㄏㄏ
: 好險郭董跟GG已經完成簽約了，不然再過幾個月復星真的可能不賣台灣了....因為優先供給中國國內
如果是復星在中國國內生產的BNT，那還真的不能進口到台灣。
: 只是這算是側面說中國國產疫苗算是不成功嗎?因為最後還是要打國外的疫苗XD